LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE
- Product NDC
- 61919-040
- 11-digit product format
- 619190040
- Labeler code
- 61919
- Product ID
- 61919-040_9c98c94b-c657-294b-e053-2a95a90ac51a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Direct Rx
- Application
- ANDA090528
- Marketing category
- ANDA
- Marketing start
- 2015-01-01
- Marketing end
- 0000-00-00
- Substance
- HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM
- Active strength
- 13 mg/1; mg/1
- Pharmacologic classes
- Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS],Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 61919-040-30 | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | 30 in 1 BOTTLE | TABLET | 30 | | 5 |
| 61919-040-90 | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | 90 in 1 BOTTLE | TABLET | 90 | | 5 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 61919-040 | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE TABLET [DIRECT RX] | 5 | Legacy NDC, 2 package rows | 20200121_dd3a32fa-28af-483d-ac21-a7d9b9248023.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 61919-040-30 | 61919004030 | 30 TABLET in 1 BOTTLE (61919-040-30) | 30 tablet | 2015-01-01 | 0000-00-00 | No | No | Current |
| 61919-040-90 | 61919004090 | 90 TABLET in 1 BOTTLE (61919-040-90) | 90 tablet | 2015-01-01 | 0000-00-00 | No | No | Current |